CC - Company ID 0001627223
The table below shows Chemours Co's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$44.00M | -$112.00M | -$290.00M | -$124.00M | $2.00M | $39.00M |
| Capital expenditure | $49.00M | $84.00M | $102.00M | $91.00M | $106.00M | $60.00M |
| Investing cash flow | -$44.00M | -$86.00M | -$101.00M | -$97.00M | -$110.00M | -$77.00M |
| Dividends paid | $13.00M | $37.00M | $37.00M |
Chemours Co reported operating cash flow of $264.00M for fiscal year 2025. That is up 141.7% from -$633.00M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $594.00M (FY 2016) to $264.00M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $37.00M |
| $40.00M |
| $41.00M |
| Stock buybacks | - | - | - | $14.00M | $144.00M | $0.00 |
| Financing cash flow | -$19.00M | -$57.00M | -$54.00M | -$68.00M | -$189.00M | -$42.00M |